Cargando…

Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19

BACKGROUND: Agitation is a disabling neuropsychiatric symptom of dementia. Pro re nata (PRN) injections of psychotropics can be administered for severe acute agitation, but little is known about the frequency of their actual use. OBJECTIVE: Characterize actual use of injectable PRN psychotropics for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hui Jue, Kusumo, Raphael W., Kiss, Alex, Tennen, Gayla, Marotta, Giovanni, Viaje, Shirley, Lanctôt, Krista L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259051/ https://www.ncbi.nlm.nih.gov/pubmed/37313488 http://dx.doi.org/10.3233/ADR-230009

Ejemplares similares

Reducing the use of oral psychotropic PRN medication in acute mental health inpatients
por: Moore, Zoe, et al.
Publicado: (2021)

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
por: Gold, Allison B, et al.
Publicado: (2011)

PRN Medicines Management for Psychotropic Medicines in Long-Term Care Settings: A Systematic Review
por: Vaismoradi, Mojtaba, et al.
Publicado: (2019)

The monitoring and use of Pro re nata (PRN) psychotropic medication for people with learning disabilities on an inpatient ward
por: Mistry, Heena
Publicado: (2021)

Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
por: Dhandapani, Asha, et al.
Publicado: (2021)

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Herrmann, Nathan, et al.
Publicado: (2013)

Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study
por: Dijk, Margaretha T, et al.
Publicado: (2022)

PRN Medicines Optimization and Nurse Education
por: Vaismoradi, Mojtaba, et al.
Publicado: (2020)

Impact of agitation in long‐term care residents with dementia in the United States
por: Fillit, Howard, et al.
Publicado: (2021)

Therapeutic Passes and Post-Discharge Outcomes in a Psychiatric Inpatient Unit: A Retrospective Study
por: Docteur, Natalia, et al.
Publicado: (2022)

The Role of Practice Research Networks (PRN) in the Development and Implementation of Evidence: The Northern Improving Access to Psychological Therapies PRN Case Study
por: Lucock, Mike, et al.
Publicado: (2017)

Prescribing of psychotropic medication for nursing home residents with dementia: a general practitioner survey
por: Cousins, Justin M, et al.
Publicado: (2017)

Nurse Staffing and Nursing Home Deficiency of Care for Inappropriate Psychotropics Use in Residents With Dementia
por: Yoon, Jung Min, et al.
Publicado: (2020)

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019)

Discomfort and agitation in older adults with dementia
por: Pelletier, Isabelle Chantale, et al.
Publicado: (2007)

Studies on Prn Variation in the Mouse Model and Comparison with Epidemiological Data
por: van Gent, Marjolein, et al.
Publicado: (2011)

PRN Treatment of Neovascular AMD with Cycles of Three Monthly Injections
por: Banaee, Touka, et al.
Publicado: (2021)

Practical Considerations of PRN Medicines Management: An Integrative Systematic Review
por: Mardani, Abbas, et al.
Publicado: (2022)

Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial
por: Kwan, Rick Yiu Cho, et al.
Publicado: (2014)

Prevalence of and associations with agitation in residents with dementia living in care homes: MARQUE cross-sectional study
por: Livingston, Gill, et al.
Publicado: (2017)

Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership
por: Coe, Antoinette B., et al.
Publicado: (2022)

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
por: Ruthirakuhan, Myuri T., et al.
Publicado: (2019)

Effect of an interactive therapeutic robotic animal on engagement, mood states, agitation and psychotropic drug use in people with dementia: a cluster-randomised controlled trial protocol
por: Moyle, Wendy, et al.
Publicado: (2015)

Management of Agitation in Behaviours That Challenge in Dementia Care: Multidisciplinary Perspectives on Non-Pharmacological Strategies
por: James, Ian Andrew, et al.
Publicado: (2023)

Severe Agitation in Dementia: An Explorative Secondary Data Analysis on the Prevalence and Associated Factors in Nursing Home Residents
por: Palm, Rebecca, et al.
Publicado: (2018)

Carer coping and resident agitation as predictors of quality of life in care home residents living with dementia: Managing Agitation and Raising Quality of Life (MARQUE) English national care home prospective cohort study
por: Laybourne, Anne, et al.
Publicado: (2018)

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
por: Carneiro, Angela M, et al.
Publicado: (2012)

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults
por: Black, Cody D., et al.
Publicado: (2018)

Gabapentin in the treatment of dementia-associated nocturnal agitation
por: Buskova, Jitka, et al.
Publicado: (2011)

Stress Cardiomyopathy in Association with Severe Agitation in Dementia
por: Amin, Hina, et al.
Publicado: (2019)

ELECTROCONVULSIVE THERAPY FOR AGITATION IN LEWY BODIES DEMENTIA
por: Echeverria, C., et al.
Publicado: (2023)

Time trends in psychotropic drug prescriptions in Dutch nursing home residents with dementia between 2003 and 2018
por: Du, Jiamin, et al.
Publicado: (2022)

Process evaluation of a tailored intervention to Reduce Inappropriate psychotropic Drug use in nursing home residents with dementia
por: Groot Kormelinck, Claudia M., et al.
Publicado: (2021)

Preliminary crystallographic characterization of PrnB, the second enzyme in the pyrrolnitrin biosynthetic pathway
por: De Laurentis, Walter, et al.
Publicado: (2006)

Identification of the minimal replicon and the origin of replication of the crenarchaeal plasmid pRN1
por: Berkner, Silvia, et al.
Publicado: (2014)

Ethical Tenets of PRN Medicines Management in Healthcare Settings: A Clinical Perspective
por: Vaismoradi, Mojtaba, et al.
Publicado: (2021)

Effects of Music on Agitation in Dementia: A Meta-Analysis
por: Pedersen, Siv K. A., et al.
Publicado: (2017)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Management of Agitation in Dementia and Effects on Inpatient Length of Stay
por: Silverstone-Simard, Isabelle, et al.
Publicado: (2021)

Challenges of Agitation in Dementia: A Plea for Early Discussion
por: Richler, Leah G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bbumog7bpunfuda2bhdprke743